doi.org/10.3899/jrheum.170334, hdl.handle.net/1765/100850
Journal of Rheumatology
Rheumatology

Kuijper, M., Buisman, L., Hazes, M., & Weel, A. (2017). Cost-effectiveness of Biological Disease-modifying Antirheumatic Drugs for the Treatment of Rheumatoid Arthritis: Implications for Clinical Practice. Journal of Rheumatology, 44(7), 965–967. doi:10.3899/jrheum.170334